ストックスクリーナーアプリを入手
496.83
3.48%
16.70
アフターアワーズ：
496.83
Vertex Pharmaceuticals Inc (VRTX) 最新ニュース
Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Intech Investment Management LLC Has $13.46 Million Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
TD Asset Management Inc Sells 247,634 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Erste Asset Management GmbH Has $26.69 Million Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Insider Selling: Vertex Pharmaceuticals (NASDAQ:VRTX) EVP Sells 58,613 Shares of Stock - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Holdings Raised by Banco Santander S.A. - MarketBeat
Insider Selling: Vertex Pharmaceuticals (NASDAQ:VRTX) EVP Sells 1,846 Shares of Stock - MarketBeat
Vertex Pharmaceuticals (NASDAQ:VRTX) EVP Ourania Tatsis Sells 260 Shares - MarketBeat
Vertex Pharmaceuticals (NASDAQ:VRTX) CAO Kristen Ambrose Sells 223 Shares - MarketBeat
Vertex Pharmaceuticals (NASDAQ:VRTX) EVP Mark Bunnage Sells 620 Shares - MarketBeat
Insider Selling: Vertex Pharmaceuticals (NASDAQ:VRTX) EVP Sells 4,910 Shares of Stock - MarketBeat
Vertex Pharmaceuticals EVP Sachdev sells $897k in shares By Investing.com - Investing.com Canada
Vertex Pharma EVP McKechnie sells $2.39m in shares By Investing.com - Investing.com Nigeria
Insider Sell: Jonathan Biller Sells Shares of Vertex Pharmaceuti - GuruFocus
Vertex Pharmaceuticals EVP Tatsis sells $126k in stock - Investing.com UK
2 Top Healthcare Stocks to Buy in February - The Motley Fool
Daiwa Securities Adjusts Vertex Pharmaceuticals PT to $561 From $500, Maintains Buy Rating - marketscreener.com
Vertex Pharma Stock: Is Wall Street Too Cautious After The Neuropathy Surprise? - AD HOC NEWS
Vertex Pharmaceuticals's Options: A Look at What the Big Money is Thinking - Benzinga
First American Trust FSB Has $1.16 Million Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
DC Circ. Talks Sharks, Moats In Vertex HHS Kickback Appeal - Law360
Kovitz Investment Group Partners LLC Boosts Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Forget AI and Weight-Loss Drugs: Why Vertex Pharmaceuticals Is the Silent Compounder You Need - NAI500
Could Vertex Stock Help Turn $100,000 Into $1 Million by 2036? - The Globe and Mail
Lansforsakringar Fondforvaltning AB publ Increases Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Bowen Hanes & Co. Inc. Sells 56,365 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Tredje AP fonden Sells 65,290 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Mitsubishi UFJ Asset Management UK Ltd. Takes Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Jupiter Asset Management Ltd. Invests $25.70 Million in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Insulet (PODD) - The Globe and Mail
HighTower Advisors LLC Sells 12,332 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex: The Quiet Biotech Compounder I'd Happily Hold Through Any Market Crash - AOL.com
Is Vertex Pharmaceuticals (VRTX) Now Offering A Compelling Entry Point After Flat One Year Returns - Yahoo Finance
Insider Sell: Atkinson Edward Morrow III Sells Shares of Vertex Pharmaceuticals Inc (VRTX) - GuruFocus
Vertex Broadens Beyond Cystic Fibrosis As CASGEVY And Pipeline Take Shape - Yahoo Finance
Madrigal Pharmaceuticals, Inc. reports strong Rezdiffra sales growth in Q4 2025; first full year of launch approaches $1 billion in net sales - AlphaStreet News
Mcrae Capital Management Inc. Boosts Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Cumberland Partners Ltd Has $3.82 Million Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Q4 2025 Earnings: Revenue Beats, Driven by CF Growth & New LaunchesNews and Statistics - IndexBox
5 Insightful Analyst Questions From Vertex Pharmaceuticals's Q4 Earnings Call - Finviz
5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q4 Earnings Call - Yahoo Finance
Insider Selling: Vertex Pharmaceuticals (NASDAQ:VRTX) EVP Sells 1,500 Shares of Stock - MarketBeat
Vertex Pharmaceuticals Stock: Is The Bull Run Over (Rating Downgrade) (NASDAQ:VRTX) - Seeking Alpha
Vertex Pharmaceuticals (VRTX) Analyst Rating Update: Canaccord G - GuruFocus
Grange Capital LLC Makes New Investment in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
PNC Financial Services Group Inc. Has $27.33 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals stock: Is Wall Street bullish or bearish? - MSN
Vertex to Participate in TD Cowen 46th Annual Health Care Conference on March 3 - BioSpace
Vertex Pharmaceuticals Topples 10% On A Series Of First-Quarter Setbacks - MSN
Narrow-Moat Vertex's Strong CF Sales Drive Growth as Non-CF Portfolio Starts to Gain Traction - Morningstar
Vertex Pharmaceuticals (VRTX) Sees Analyst Rating Maintained wit - GuruFocus
Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock - Yahoo Finance
HC Wainwright & Co. Raises Vertex Pharmaceuticals (VRTX) Price T - GuruFocus
Vanguard Group Inc. Boosts Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
NEOS Investment Management LLC Purchases 37,296 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Skandinaviska Enskilda Banken AB publ Has $60.39 Million Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Public Sector Pension Investment Board Has $8.78 Million Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Stock: Is Wall Street Bullish or Bearish? - Barchart.com
Oppenheimer Upgrades Vertex Pharmaceuticals (VRTX) - Nasdaq
1.41%
0.60%
大文字化:
|
ボリューム (24 時間):